35 results
8-K
EX-10.1
RVPH
Reviva Pharmaceuticals Holdings Inc.
17 Nov 23
Reviva Announces $30 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:05pm
of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii
424B4
RVPH
Reviva Pharmaceuticals Holdings Inc.
18 Oct 22
Prospectus supplement with pricing info
7:01am
, labeling, packaging, storage, approval, advertising, promotion, sale and distribution, are subject to comprehensive regulation by the FDA and other … , along with the manufacturing processes, post-approval clinical data, labeling, packaging, distribution, adverse event reporting, storage
8-K
EX-10.2
h3no0 amvka
7 Sep 22
Entry into a Material Definitive Agreement
4:18pm
8-K
EX-10.1
5bcbs 44o9l9tyfz
7 Sep 22
Entry into a Material Definitive Agreement
4:18pm
S-3
EX-1.2
ljh pt21q6muktu
26 Jan 22
Shelf registration
4:15pm
424B4
dmuzl211o3t
28 May 21
Prospectus supplement with pricing info
4:06pm
424B4
kwok 5d0t2
17 May 21
Prospectus supplement with pricing info
12:00am
POS AM
sdlqm4 xcc
12 May 21
Prospectus update (post-effective amendment)
4:34pm
424B4
soqf93 0oexhp5fhr3y
29 Mar 21
Prospectus supplement with pricing info
4:07pm